Penn Medicine 2020 Updates in Oncology
2020 ASCO CRC Update: Encorafenib and Cetuximab in BRAF V600 mCRC, IO in MSI-high mCRC, DFS With TNT and Selective Waiting / TME vs. SoC
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Jennifer Eads
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Jennifer Eads
Login to view comments.
Click here to Login